Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components

Int J Mol Sci. 2022 Apr 15;23(8):4383. doi: 10.3390/ijms23084383.

Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastatic route using ascites, known as the transcoelomic root. However, studies on ascites and contained cellular components have not yet been sufficiently clarified. In this review, we focus on the significance of accumulating ascites, contained EOC cells in the form of spheroids, and interaction with non-malignant host cells. To become resistant against anoikis, EOC cells form spheroids in ascites, where epithelial-to-mesenchymal transition stimulated by transforming growth factor-β can be a key pathway. As spheroids form, EOC cells are also gaining the ability to attach and invade the peritoneum to induce intraperitoneal metastasis, as well as resistance to conventional chemotherapy. Recently, accumulating evidence suggests that EOC spheroids in ascites are composed of not only cancer cells, but also non-malignant cells existing with higher abundance than EOC cells in ascites, including macrophages, mesothelial cells, and lymphocytes. Moreover, hetero-cellular spheroids are demonstrated to form more aggregated spheroids and have higher adhesion ability for the mesothelial layer. To improve the poor prognosis, we need to elucidate the mechanisms of spheroid formation and interactions with non-malignant cells in ascites that are a unique tumor microenvironment for EOC.

Keywords: anoikis; ascites; genetic evolution; hetero-cellular spheroid; macrophage; mesothelial cell; metastasis; ovarian cancer; resistance to chemotherapy; spheroid.

Publication types

  • Review

MeSH terms

  • Ascites / pathology
  • Carcinoma, Ovarian Epithelial
  • Cell Line, Tumor
  • Female
  • Humans
  • Neoplasms, Glandular and Epithelial*
  • Ovarian Neoplasms* / pathology
  • Spheroids, Cellular / metabolism
  • Tumor Microenvironment